|
EnablexDrug - Enablex The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Darifenacin Hydrobromide
Strength -
EQ 7.5MG BASE
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
021513
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 22, 2004
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Novartis Pharmaceuticals Corp
Enablex
Rev-eyes 0.5% Solution/drops; Ophthalmic
Aczone 5% Gel; Topical Dapsone 100mg Tablet; Oral Dapsone 25mg Tablet; Oral Cubicin 250mg/vial Injectable; Iv (infusion) Cubicin 500mg/vial Injectable; Iv (infusion) Enablex Eq 15mg Base Tablet, Extended Release; Oral Enablex Eq 7.5mg Base Tablet, Extended Release; Oral Dantrolene Sodium 50mg Capsule; Oral Dantrium 20mg/vial Injectable; Injection NewDrugInformation |